ArticleJournal of ophthalmology2020

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration.

Zongyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.